Clinical Trials In Michigan
Discover hundreds of clinical trials in Michigan.
Search clinical trials in Michigan by city, condition or phase.
Academic-Community EPINET (AC-EPINET)
Sponsor:
Indiana University
Location:
Code:
NCT04497857
Conditions
Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorders
Major Depression with Psychotic Features
Bipolar Disorder with Psychotic Features
Eligibility Criteria
Sex: All
Age: 16 - 35
Healthy Volunteers: Not accepted
Interventions
Coordinated Specialty Care (CSC)
Phase 1 Trial of ST-001 NanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Sponsor:
SciTech Development, LLC
Location:
Code:
NCT04234048
Conditions
T-cell Lymphoma
Cutaneous/Peripheral T-Cell Lymphoma
Peripheral T-cell Lymphoma
Peripheral T-Cell Lymphoma, Not Classified
Primary Cutaneous T-cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Fenretinide
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Sponsor:
Janssen Research & Development, LLC
Location:
Code:
NCT05754957
Conditions
Acute Coronary Syndrome
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Milvexian
Placebo
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell Lymphoma
Sponsor:
Jiangsu Simcere Pharmaceutical Co., Ltd.
Location:
Code:
NCT05569057
Conditions
Advanced Solid Tumor
Cutaneous T-cell Lymphoma (CTCL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
SIM1811-03
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
Sponsor:
University of Michigan
Location:
Code:
NCT05769348
Conditions
Chronic Migraine
Eligibility Criteria
Sex: All
Age: 18 - 65
Healthy Volunteers: Not accepted
Interventions
HD-tDCS Active Protocol
HD-tDCS Sham Protocol
The Back Pain Consortium Research Program Study
Sponsor:
University of Michigan
Location:
Code:
NCT04870957
Conditions
Chronic Low-back Pain
Eligibility Criteria
Sex: All
Age: 25 - 70
Healthy Volunteers: Not accepted
Interventions
PainGuide
MBSR
PT and exercise
Self -administered acupressure
Duloxetine
A Study of Dabrafenib and/or Trametinib in Patients With Relapsed and/or Refractory Multiple Myeloma
Sponsor:
Massachusetts General Hospital
Location:
Code:
NCT03091257
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Dabrafenib
Trametinib